Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia K Delrahim

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Psychopharmacology Bulletin|July 15, 2003
Long-term antidepressant treatmentKatia K Delrahim, Rachel Maddux, Mark Hyman Rapaport
CNS Spectrums|February 24, 2004
Quality of life in geriatric patients with mood and anxiety disordersRachel E Maddux, Katia K Delrahim, Mark H Rapaport
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Biological Psychiatry|June 15, 2005
Celecoxib augmentation of continuously ill patients with schizophreniaMark Hyman Rapaport, Katia K Delrahim, Catherine J Bresee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Psychopharmacology Bulletin|July 15, 2003
Long-term antidepressant treatmentKatia K Delrahim, Rachel Maddux, Mark Hyman Rapaport
CNS Spectrums|February 24, 2004
Quality of life in geriatric patients with mood and anxiety disordersRachel E Maddux, Katia K Delrahim, Mark H Rapaport
Biological Psychiatry|March 5, 2003
Studies characterizing 60 kda autoantibodies in subjects with schizophreniaXiao-Fen Wang, Dunrui Wang, Weiguo Zhu, et al.
Biological Psychiatry|June 15, 2005
Celecoxib augmentation of continuously ill patients with schizophreniaMark Hyman Rapaport, Katia K Delrahim, Catherine J Bresee, et al.
Pageof 1